Episode

Journal Club#4: arterial lines, oxygen and fibrinogen

Podcast
TRAUMA-ING
Published
Dec 4, 2025
Duration seconds
1613
Processing state
not_requested
Canonical source
https://www.trauma-ing.com/podcast/journal-club4-arterial-lines-oxygen-and-fibrinogen
Audio
https://static1.squarespace.com/static/66ec702b0012414ab9214ef3/t/693183174bbbdf391183dfb7/1764852559968/017+JC3.mp3
JSON
/v1/public/podcasts/trauma-ing-7049449/episodes/journal-club-4-arterial-lines-oxygen-and-fibrinogen
Markdown
/podcast/trauma-ing-7049449/journal-club-4-arterial-lines-oxygen-and-fibrinogen.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/trauma-ing-7049449/episodes/journal-club-4-arterial-lines-oxygen-and-fibrinogen/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/trauma-ing-7049449/journal-club-4-arterial-lines-oxygen-and-fibrinogen.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this Trauma-ing Journal Club episode, we break down three timely studies shaping trauma care at the bedside and in the bay. First, we look at Perera et al.’s prehospital comparison of non-invasive versus arterial blood pressure monitoring, where NIBP consistently missed the mark in both shock and hypertension—who then should get art lines and when? We then dive into the TRAUMOX2 randomized trial, which challenges our instinct to “turn the oxygen up,” showing no mortality difference between restrictive and liberal oxygen strategies but hinting at fewer pulmonary complications with moderate targets. Finally, we unpack Burt et al.’s meta-analysis on early fibrinogen replacement in traumatic haemorrhage, finding no clear mortality or transfusion benefit despite its widespread use and highlighting the need for stronger evidence in the sickest, most coagulopathic patients. Go to www.trauma-ing.com for more FOAM trauma stuff